SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001759425-24-000012
Filing Date
2024-04-23
Accepted
2024-04-23 16:21:09
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A mirm-schedule14addtlmateri.htm DEFA14A 12182
2 noticepage1.jpg GRAPHIC 180761
3 noticepage2.jpg GRAPHIC 150646
  Complete submission text file 0001759425-24-000012.txt   458936
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38981 | Film No.: 24865095
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)